Visceral leishmaniasis, which is commonly known as Kala-azar in India, is fatal in over 95% of the cases, if left untreated.
The post New biomolecules to fight drug resistance in Kala-azar appeared first on BioTech Times.
About the Author: Biotech Today
You might like
What Makes a Biotech Executive Stand Out?
5 days ago
1 Likes
4
Biomimicry in Biotech: Taking Inspiration from Nature
7 days ago
0 Likes
10